BioRestorative Therapies Inc (BRTX) concluded trading on Thursday at a closing price of $1.96, with 14.42 million shares of worth about $28.26 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.32% during that period and on February 20, 2025 the price saw a loss of about -3.45%. Currently the company’s common shares owned by public are about 6.92M shares, out of which, 5.05M shares are available for trading.
Stock saw a price change of -17.99% in past 5 days and over the past one month there was a price change of -7.55%. Year-to-date (YTD), BRTX shares are showing a performance of 37.06% which increased to 31.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.03 but also hit the highest price of $2.55 during that period. The average intraday trading volume for BioRestorative Therapies Inc shares is 78.98K. The stock is currently trading -15.05% below its 20-day simple moving average (SMA20), while that difference is up 3.44% for SMA50 and it goes to 17.85% higher than SMA200.
BioRestorative Therapies Inc (NASDAQ: BRTX) currently have 6.92M outstanding shares and institutions hold larger chunk of about 13.94% of that.
The stock has a current market capitalization of $13.57M and its 3Y-monthly beta is at 63.39. It has posted earnings per share of -$0.71 in the same period. It has Quick Ratio of 2.94 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BRTX, volatility over the week remained 14.01% while standing at 9.67% over the month.
Stock’s fiscal year EPS is expected to rise by 58.87% while it is estimated to decrease by -3.08% in next year. EPS is likely to shrink at an annualized rate of 33.74% for next 5-years, compared to annual growth of 79.34% made by the stock over the past 5-years.
